Creative communication tools can bring research findings to a wider audience
Once upon a time, a conference presentation and publication in an academic journal were the extents of a researcher ' s responsibility to share the results of their research. People assumed that those who could use the findings to make a difference would be actively looking for the latest information. They would know where to look, and when they came across the academic paper, they would have the time and knowledge to read and make sense of it. We are increasingly recognising that most evidence users do not have the time and capacity to do this. Besides, research is often behind paywalls and inaccessible. In the words of ...
Source: Current Awareness Service for Health (CASH) - September 27, 2022 Category: Consumer Health News Source Type: news

Study to assess impact of national scheme to reduce head trauma injuries in babies
A national programme introduced to reduce rates of abusive head trauma in babies will be assessed as part of a new research study led by (UWE Bristol) in collaboration with the University of Bristol and the National Institute for Health and Care Applied Research Collaboration West (NIHR ARC West). (Source: University of Bristol news)
Source: University of Bristol news - September 22, 2022 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Who is most at risk of long-COVID after a hospital admission for COVID-19?, NIHR Dissemination Centre (published 21st September 2022)
Expert commentary is provided for a study of 1,077 patients discharged following short term treatment for COVID which found that only 29% of patients felt fully recovered at 12 months. Post-COVID anxiety prevalence did not reduce over time (24% at 5 months and 22% at 12 months). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 22, 2022 Category: Consumer Health News Source Type: news

Preterm birth delay drugs safe for global reduction in neonatal death
Women around the world should be able to access the best medical treatments that help to delay preterm births and improve neonatal outcomes,updated Cochrane network meta-analysis suggests.Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm, and where more research is needed. Our work is recognised as the international gold standard for...
Source: Cochrane News and Events - August 9, 2022 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Patient-initiated follow-up: will it free up capacity in outpatient care?
With the number of outpatient hospital appointments in England recently as high as 125 million per year and a huge elective care backlog following the Covid-19 pandemic, patient-initiated follow-up on outpatient appointments has been touted as a potential solution in appropriate cases. But can it free up much-needed capacity while maintaining quality of patient experience and outcomes? As the NHS begins to expand its use of the approach, the NIHR RSET research team has conducted a first review of the available evidence (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 4, 2022 Category: Consumer Health News Source Type: news

COVID-19 vaccine study calls on pregnant women to help build upon booster dose guidance, NIHR
An on-going national COVID-19 vaccine study is urging more pregnant women across the UK to step forward, join hundreds of other volunteers and help researchers discover the most effective use of booster vaccines during pregnancy. The 2 External 0 0 0 Preg-CoV study false https://vaccine.ac.uk/research/preg-cov-trial/ false false%> currently has around 300 pregnant women taking part nationally. It aims to determine the best vaccine schedules and doses to protect women and their babies against COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 25, 2022 Category: Consumer Health News Source Type: news

Platform trial rules out treatments for COVID-19, NIHR Evidence
This research shows that adding doxycycline, azithromycin or colchicine to usual care provides no meaningful benefit to people in the community with COVID-19. They should not be used. Antibiotics should always be used sparingly to prevent bacteria becoming resistant to them. Use of any drug which is not effective puts people at unnecessary risk of side effects, and wastes money. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 18, 2022 Category: Consumer Health News Source Type: news

“ Hope saved my life ” : How the Hope project helped men at risk of suicide
A project to help men aged 30-64 who are at risk of suicide has saved lives and reduced depression and suicidal thoughts, a study by National Institute for Health and Care Research (NIHR) funded researchers at the University of Bristol has shown. Hope, run by mental health charity Second Step, aims to help men in mental health crisis because of debt, financial, employment or welfare difficulties. (Source: University of Bristol news)
Source: University of Bristol news - July 13, 2022 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news

First in human study to assess knee cartilage repair implant launches at Southmead Hospital
A new first in human study to assess the safety and performance of FibroFix Cartilage P ™ (FibroFix ™ ), an innovative implant that repairs knee cartilage, is starting at Southmead Hospital, Bristol. The FFLEX clinical trial has been awarded nearly £ 1.2million by the National Institute for Health and Care Research (NIHR) and will be led by Orthox, the company behind FibroFix ™ , and researchers from the University of Bristol. (Source: University of Bristol news)
Source: University of Bristol news - July 13, 2022 Category: Universities & Medical Training Tags: Research, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

Interrupting treatment of vulnerable people on immune-suppressing medicines doubles their antibody response to COVID-19 booster vaccination, NIHR
Interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination can double their antibody response to the jab, new research finds. The VROOM trial will have implications for people on immune-supressing medicines, who are among the millions of clinically vulnerable patients advised to ' shield ' during the pandemic. The study, funded by an NIHR and the Medical Research Council (MRC) partnership, and led by researchers at the University of Nottingham, is now published in the journal Lancet Respiratory Medicine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 4, 2022 Category: Consumer Health News Source Type: news

Sex, age and existing health problems increase risk of long COVID, NIHR
Women, people aged 50-60, and people with poor pre-pandemic mental or physical health are more at risk of long COVID, according to research funded by the NIHR and UK Research and Innovation. Around two million people in the UK are affected by long COVID, experiencing symptoms for 12 weeks or more after they ' ve been infected. The new research looked at data from 10 UK long-term studies established before the pandemic, which have tracked participants over many years. Data from these studies were combined with 1.1 million anonymised electronic health records from English general practices. (Source: Current Awareness Ser...
Source: Current Awareness Service for Health (CASH) - July 4, 2022 Category: Consumer Health News Source Type: news

NIHR alert: How to improve discussions about osteoarthritis in primary care
Expert commentary is provided on review highlighting areas in which this group has different priorities and concerns to those providing their care, that concluded consultations could be improved if professionals actively listened to people more, and validated their concerns (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 27, 2022 Category: Consumer Health News Source Type: news

COVID-19 vaccine study supports flexible intervals in mixed Pfizer and Oxford/AstraZeneca schedules, NIHR
A standard two-dose Pfizer-BioNTech or Oxford-AstraZeneca vaccine schedule showed a greater antibody increase when given at a 12-week interval, compared to a four-week interval. These are the latest findings from the University of Oxford-led Com-COV study, supported by the National Institute for Health and Care research (NIHR), which has published a paper in the Lancet Respiratory Medicine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 9, 2022 Category: Consumer Health News Source Type: news

NIHR Alert: Platform trial rules out treatments for COVID-19, NIHR
Expert commentary is provided for a trial which found adding doxycycline, azithromycin or colchicine to usual care provides no benefit to people in the community with COVID-19. These data are useful as preventing ineffective antibiotic use is critical to reduce drug resistance. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 6, 2022 Category: Consumer Health News Source Type: news

COVID-19 vaccination associated with reduced risk of long COVID, NIHR
An NIHR-supported study of more than 28,000 people has shown that vaccination against COVID-19 is associated with a moderate reduction in the risk of experiencing long COVID. The study found that a first vaccine dose reduced the likelihood of long COVID symptoms by more than 12% in people who had tested positive for COVID-19 before vaccination. A second dose was associated with a further 9% reduction in the odds of long COVID. Some people who get COVID-19 experience symptoms that last weeks or months after the infection has gone, a condition known as post-COVID-19 syndrome or ' long COVID ' . Preliminary research suggests ...
Source: Current Awareness Service for Health (CASH) - June 1, 2022 Category: Consumer Health News Source Type: news